<?xml version="1.0" encoding="UTF-8"?>
<ClinicalUseDefinition xmlns="http://hl7.org/fhir"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://hl7.org/fhir http://hl7.org/fhir/clinicalusedefinition.xsd">
  <id value="example-interaction-azoles"/>
  <meta>
      <profile value="http://hl7.org/fhir/uv/order-catalog/StructureDefinition/InteractionDefinition"/>
  </meta>
  <language value="en-US"/>
  <type value="interaction"/>
  <interaction> 
    <interactant> 
      <itemCodeableConcept> 
        <coding> 
          <system value="http://ema.europa.eu/example/interactant"/> 
          <code value="alphaconazole"/> 
        </coding> 
      </itemCodeableConcept> 
    </interactant> 
    <interactant> 
      <itemCodeableConcept> 
        <coding> 
          <system value="http://ema.europa.eu/example/interactant"/> 
          <code value="betaconazole"/> 
        </coding> 
      </itemCodeableConcept> 
    </interactant> 
    <type> 
      <coding> 
        <system value="http://ema.europa.eu/example/interactionsType"/> 
        <code value="Inhibitor"/> 
      </coding> 
    </type> 
    <effect> 
      <concept> 
        <text value="Increased plasma concentration"/> 
      </concept> 
    </effect> 
    <management> 
      <text value="Careful monitoring of dose"/> 
    </management> 
  </interaction>
</ClinicalUseDefinition> 
